My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 478

    1.

    Rational use of new and existing disease-modifying agents in rheumatoid arthritis.

    Kremer JM.

    Ann Intern Med. 2001 Apr 17;134(8):695-706. Review.PMID: 11304108 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

    Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

    Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.PMID: 17049139 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept.

    Fleischmann R, Iqbal I, Nandeshwar P, Quiceno A.

    Drug Saf. 2002;25(3):173-97. Review.PMID: 11945114 [PubMed - indexed for MEDLINE]Related articles

    4.

    Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs.

    Dale J, Alcorn N, Capell H, Madhok R.

    Nat Clin Pract Rheumatol. 2007 Aug;3(8):450-8; quiz, following 478. Review.PMID: 17664952 [PubMed - indexed for MEDLINE]Related articles

    5.

    Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

    Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

    Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.PMID: 16948890 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Newer approaches to the treatment of rheumatoid arthritis.

    Finesilver AG.

    WMJ. 2003;102(7):34-7. Review.PMID: 14711022 [PubMed - indexed for MEDLINE]Related articles

    7.

    New antirheumatic drugs: any real added value? A critical overview of regulatory criteria for their marketing approval.

    Bertele' V, Assisi A, Di Muzio V, Renzo D, Garattini S.

    Eur J Clin Pharmacol. 2007 Sep;63(9):879-89. Epub 2007 Jul 24.PMID: 17646975 [PubMed - indexed for MEDLINE]Related articles

    8.

    Infliximab: a pharmacoeconomic review of its use in rheumatoid arthritis.

    Lyseng-Williamson KA, Foster RH.

    Pharmacoeconomics. 2004;22(2):107-32. Review.PMID: 14731052 [PubMed - indexed for MEDLINE]Related articles

    9.

    Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.

    Culy CR, Keating GM.

    Drugs. 2002;62(17):2493-537. Review.PMID: 12421111 [PubMed - indexed for MEDLINE]Related articles

    10.

    Advances in the medical management of rheumatoid arthritis.

    Scott DL.

    Hosp Med. 2002 May;63(5):294-7. Review.PMID: 12066349 [PubMed - indexed for MEDLINE]Related articles

    11.

    Rheumatoid arthritis: more aggressive approach improves outlook.

    Weinblatt ME.

    Cleve Clin J Med. 2004 May;71(5):409-13. Review.PMID: 15195775 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    [New drugs and treatment strategies for rheumatoid arthritis]

    Fantini F.

    Recenti Prog Med. 2003 Sep;94(9):361-79. Review. Italian. PMID: 12942798 [PubMed - indexed for MEDLINE]Related articles

    13.

    Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis.

    Nurmohamed MT, Dijkmans BA.

    Drugs. 2005;65(5):661-94. Review.PMID: 15748099 [PubMed - indexed for MEDLINE]Related articles

    14.

    Rheumatoid arthritis.

    Emery P, Suarez-Almazor M.

    Clin Evid. 2003 Jun;(9):1349-71. Review. No abstract available. PMID: 15366179 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept]

    Tijhuis GJ, van de Putte LB, Breedveld FC.

    Ned Tijdschr Geneeskd. 2001 Sep 29;145(39):1880-5. Review. Dutch. PMID: 11605312 [PubMed - indexed for MEDLINE]Related articles

    16.

    Treatment options for rheumatoid arthritis: celecoxib, leflunomide, etanercept, and infliximab.

    Luong BT, Chong BS, Lowder DM.

    Ann Pharmacother. 2000 Jun;34(6):743-60. Review.PMID: 10860137 [PubMed - indexed for MEDLINE]Related articles

    17.

    Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.

    van der Heijde D, Klareskog L, Landewé R, Bruyn GA, Cantagrel A, Durez P, Herrero-Beaumont G, Molad Y, Codreanu C, Valentini G, Zahora R, Pedersen R, MacPeek D, Wajdula J, Fatenejad S.

    Arthritis Rheum. 2007 Dec;56(12):3928-39.PMID: 18050208 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    [New basic therapeutic drugs from the viewpoint of evidence-based therapy]

    Schattenkirchner M.

    Z Rheumatol. 2001 Dec;60(6):473-6. German. PMID: 11826744 [PubMed - indexed for MEDLINE]Related articles

    19.

    Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis.

    Donahue KE, Gartlehner G, Jonas DE, Lux LJ, Thieda P, Jonas BL, Hansen RA, Morgan LC, Lohr KN.

    Ann Intern Med. 2008 Jan 15;148(2):124-34. Epub 2007 Nov 19. Review.PMID: 18025440 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Medical therapy: where are we now?

    Resman-Targoff BH.

    Am J Health Syst Pharm. 2006 Sep 15;63(18 Suppl 4):S11-8. Review.PMID: 16960243 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity